Cytokine Levels in Conversion Disorder

Proinflammatory Cytokine Levels in Patients With Conversion Disorder

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00971360

Enrollment

Registered

2009-09-03

Start date

2009-09-30

Completion date

2010-09-30

Last updated

2010-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conversion Disorder

Keywords

conversion, cytokine, inflammation

Brief summary

The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with controls.

Interventions

OTHERconversion disorder

Proinflammatory cytokine levels in conversion disorder

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of Alzheimer's Disease

Exclusion criteria

* Autoimmune disease * Neurological disease * Any organic disorder that could possibly affect proinflammatory cytokines * Pregnancy * Any drug usage within 2 weeks * Any active or passive immunization within 6 months * Any other DSM-IV axis I psychiatric disorder * Mental retardation * Developmental disorder of childhood

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026